Trial
NCT00469469
Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Genentech, Inc.
Condition
Adrenocortical Carcinoma
Intervention
Bevacizumab
Why stopped
unable to enroll subjects into the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-22